White label ELPA - ClinicalTrials.eu

Study on the Use of Methylprednisolone Sodium Succinate for Treating Patients with Acute Myocarditis and Mildly Reduced Heart Function

Recruiting

3 1 1
Investigated diseases:
Investigated drugs:
- Methylprednisolone Sodium Succinate
- Sodium Chloride
Study on Bevacizumab for Patients with Symptomatic Cerebral Arteriovenous Malformations

Recruiting

2 1 1
Investigated diseases:
- Cerebral arteriovenous malformation haemorrhagic
Investigated drugs:
- Bevacizumab
Study on Dapagliflozin for Slowing Kidney Disease in Adolescents and Young Adults with Alport Syndrome

Recruiting

3 1 1
Investigated diseases:
- Alport’s syndrome
Investigated drugs:
- Placebo
- Dapagliflozin
Study on Dapagliflozin for Patients with Severe Chronic Kidney Disease to Improve Kidney and Heart Health Outcomes

Recruiting

3 1 1
Investigated diseases:
- Chronic kidney disease
Investigated drugs:
- Dapagliflozin
Study on Repotrectinib for Children and Young Adults with Advanced Solid Tumors with ALK, ROS1, or NTRK1-3 Alterations

Recruiting

1 1 1
Investigated diseases:
- Neoplasm
Investigated drugs:
- Repotrectinib
Long-Term Follow-Up Study for Patients Treated with CAR T-Cell Therapy Using PHE885, YTB323, and Tisagenlecleucel

Recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
+6
Study on the Early Use of Risdiplam for Children with Spinal Muscular Atrophy After Gene Therapy

Recruiting

3 1 1 1
Investigated diseases:
- Spinal muscular atrophy
Investigated drugs:
- Risdiplam
Study on the Safety and Effectiveness of Rebisufligene Etisparvovec for Patients with Mucopolysaccharidosis Type IIIA

Recruiting

2 1 1
Investigated diseases:
- Mucopolysaccharidosis III
Investigated drugs:
- Rebisufligene Etisparvovec
Long-term safety study of rebisufligene etisparvovec gene therapy in patients previously treated for Mucopolysaccharidosis type IIIA

Recruiting

3 1 1
Investigated diseases:
- Mucopolysaccharidosis III
Investigated drugs:
- Rebisufligene Etisparvovec
Study on Fecal Microbiota Transfer with Vancomycin, Atezolizumab, and Bevacizumab for Patients with Advanced Liver Cancer

Recruiting

2 1 1
Investigated diseases:
- Hepatocellular carcinoma
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies